{ "cik": 1478320, "cik_padded": "0001478320", "entityName": "Adaptive Biotechnologies Corp", "fiscal_years": [ { "accn": "0001193125-26-076902", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2959000.0, "cash": 70495000.0, "eps_diluted": -0.39, "free_cash_flow": -48945000.0, "net_income": -59499000.0, "operating_cash_flow": -45986000.0, "operating_income": -57123000.0, "revenue": 276976000.0, "stockholders_equity": 218793000.0, "total_assets": 512736000.0, "total_liabilities": 287735000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3151014886216652, "net_margin": -0.21481644619028364, "operating_margin": -0.2062380856103056, "revenue_growth_yoy": 0.547723754868488, "roa_avg2y": -0.11310392809890962, "roa_period_end": -0.11604217375023404, "roe_avg2y": -0.2823189451058358, "roe_period_end": -0.271941972549396 } }, { "accn": "0001193125-26-076902", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3664000.0, "cash": 47920000.0, "eps_diluted": -1.08, "free_cash_flow": -98876000.0, "net_income": -159492000.0, "operating_cash_flow": -95212000.0, "operating_income": -162549000.0, "revenue": 178957000.0, "stockholders_equity": 202709000.0, "total_assets": 539376000.0, "total_liabilities": 336891000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.6619439689406983, "net_margin": -0.8912308543393107, "operating_margin": -0.9083131702028979, "revenue_growth_yoy": 0.050981935211069085, "roa_avg2y": -0.26570707449334036, "roa_period_end": -0.2956972501557355, "roe_avg2y": -0.6241029293221785, "roe_period_end": -0.7868027566610265 } }, { "accn": "0001193125-26-076902", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 10697000.0, "cash": 65064000.0, "eps_diluted": -1.56, "free_cash_flow": -167021000.0, "net_income": -225250000.0, "operating_cash_flow": -156324000.0, "operating_income": -227035000.0, "revenue": 170276000.0, "stockholders_equity": 308399000.0, "total_assets": 661134000.0, "total_liabilities": 352856000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1441541639240076, "net_margin": -1.3228523103666987, "operating_margin": -1.3333352909394158, "revenue_growth_yoy": -0.08111900187795454, "roa_avg2y": -0.2968207565009017, "roa_period_end": -0.340702489964213, "roe_avg2y": -0.583123210504243, "roe_period_end": -0.7303849882781721 } }, { "accn": "0000950170-25-030913", "filed": "2025-03-03", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 16349000.0, "cash": 90030000.0, "eps_diluted": -1.4, "free_cash_flow": -200294000.0, "net_income": -200191000.0, "operating_cash_flow": -183945000.0, "operating_income": -200186000.0, "revenue": 185308000.0, "stockholders_equity": 464165000.0, "total_assets": 856617000.0, "total_liabilities": 392519000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8456454062671679, "net_margin": -1.0803149351350185, "operating_margin": -1.0802879530295508, "revenue_growth_yoy": 0.2006168040221842, "roa_avg2y": -0.22493863629596378, "roa_period_end": -0.23369954133527585, "roe_avg2y": -0.3748344110463162, "roe_period_end": -0.4312927515000054 } }, { "accn": "0000950170-24-023095", "filed": "2024-02-29", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 61746000.0, "cash": 139065000.0, "eps_diluted": -1.48, "free_cash_flow": -254473000.0, "net_income": -207279000.0, "operating_cash_flow": -192727000.0, "operating_income": -208966000.0, "revenue": 154344000.0, "stockholders_equity": 603992000.0, "total_assets": 923344000.0, "total_liabilities": 319242000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5285533583226268, "net_margin": -1.3429676566630382, "operating_margin": -1.353897786762038, "revenue_growth_yoy": 0.5688235652863328, "roa_avg2y": -0.20323881558498605, "roa_period_end": -0.2244872983416798, "roe_avg2y": -0.30770498300993576, "roe_period_end": -0.3431816977708314 } }, { "accn": "0000950170-23-002792", "filed": "2023-02-14", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 18803000.0, "cash": 123436000.0, "eps_diluted": -1.11, "free_cash_flow": -168486000.0, "net_income": -146227000.0, "operating_cash_flow": -149683000.0, "operating_income": -152817000.0, "revenue": 98382000.0, "stockholders_equity": 743266000.0, "total_assets": 1116414000.0, "total_liabilities": 373148000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5020383012272861, "net_margin": -1.4863186355227582, "revenue_growth_yoy": 0.15646930211235321, "roa_avg2y": -0.1441571910508913, "roa_period_end": -0.13097918872389633, "roe_avg2y": -0.22251608264443945, "roe_period_end": -0.19673575812696936 } }, { "accn": "0001564590-22-005228", "filed": "2022-02-15", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11200000.0, "cash": 96576000.0, "free_cash_flow": 194204000.0, "net_income": -68606000.0, "operating_cash_flow": 205404000.0, "operating_income": -78391000.0, "revenue": 85071000.0, "stockholders_equity": 571039000.0, "total_assets": 912302000.0, "total_liabilities": 341263000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5976176758505111, "net_margin": -0.8064557839921948, "operating_margin": -0.9214773542100129, "revenue_growth_yoy": 0.5283222248172035, "roa_avg2y": -0.11021132699861043, "roa_period_end": -0.07520097511569633, "roe_avg2y": -0.43847926193649, "roe_period_end": -0.1201424070860309 } }, { "accn": "0001564590-21-008124", "filed": "2021-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6299000.0, "cash": 55030000.0, "free_cash_flow": -38558000.0, "net_income": -46447000.0, "operating_cash_flow": -32259000.0, "operating_income": -49756000.0, "revenue": 55663000.0, "stockholders_equity": -258112000.0, "total_assets": 332688000.0, "total_liabilities": 29942000.0 }, "period_end": "2018-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.8344322081095163, "operating_margin": -0.8938792375545694, "revenue_growth_yoy": 0.4477476071577195, "roa_period_end": -0.13961128745250806, "roe_avg2y": 0.1924354916226115 } }, { "accn": "0001564590-21-008124", "filed": "2021-02-24", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 2421000.0, "free_cash_flow": -37279000.0, "net_income": -42831000.0, "operating_cash_flow": -34858000.0, "operating_income": -44475000.0, "revenue": 38448000.0, "stockholders_equity": -224616000.0 }, "period_end": "2017-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -1.113998127340824, "operating_margin": -1.1567571785268413, "roe_avg2y": 0.20673826475202123 } }, { "accn": "0001564590-20-006830", "filed": "2020-02-26", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -189734000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-076902", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001478320.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001478320.json" }, "ticker": "ADPT" }